Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
May 15, 2007
Shipshape to nurse
Stuart Pearson
Journal of Medicinal Chemistry
|
March 16, 2012
Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation
Richard A Ward, Claire Brassington, Alexander L Breeze, et al.
ACS Medicinal Chemistry Letters
|
August 22, 2018
Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors
Bernard Barlaam, Elaine Cadogan, Andrew Campbell, et al.
Journal of Medicinal Chemistry
|
February 12, 2013
Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases
Matt Addie, Peter Ballard, David Buttar, et al.
Bioorganic & Medicinal Chemistry
|
April 19, 2022
Identification and optimisation of a pyrimidopyridone series of IRAK4 inhibitors
Iain A Cumming, Sébastien L Degorce, Anna Aagaard, et al.
Bioorganic & Medicinal Chemistry
|
October 22, 2020
Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors
Sébastien L Degorce, Anna Aagaard, Rana Anjum, et al.
Journal of Medicinal Chemistry
|
September 12, 2018
Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal Tumors
Jason G Kettle, Rana Anjum, Evan Barry, et al.
Journal of Medicinal Chemistry
|
September 28, 2024
Optimization of Potent, Efficacious, Selective and Blood-Brain Barrier Penetrating Inhibitors Targeting EGFR Exon20 Insertion Mutations
Clare Thomson, Erin Braybrooke, Nicola Colclough, et al.
Journal of Medicinal Chemistry
|
January 30, 2026
Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer
James S Scott, Laura Evans, Peter C Astles, et al.
Journal of Medicinal Chemistry
|
January 27, 2025
Highly Optimized CNS Penetrant Inhibitors of EGFR Exon20 Insertion Mutations
William McCoull, Clare Thomson, Erin Braybrooke, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
May 15, 2007
Shipshape to nurse
Stuart Pearson
Journal of Medicinal Chemistry
|
March 16, 2012
Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation
Richard A Ward, Claire Brassington, Alexander L Breeze, et al.
ACS Medicinal Chemistry Letters
|
August 22, 2018
Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors
Bernard Barlaam, Elaine Cadogan, Andrew Campbell, et al.
Journal of Medicinal Chemistry
|
February 12, 2013
Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases
Matt Addie, Peter Ballard, David Buttar, et al.
Bioorganic & Medicinal Chemistry
|
April 19, 2022
Identification and optimisation of a pyrimidopyridone series of IRAK4 inhibitors
Iain A Cumming, Sébastien L Degorce, Anna Aagaard, et al.
Bioorganic & Medicinal Chemistry
|
October 22, 2020
Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors
Sébastien L Degorce, Anna Aagaard, Rana Anjum, et al.
Journal of Medicinal Chemistry
|
September 12, 2018
Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal Tumors
Jason G Kettle, Rana Anjum, Evan Barry, et al.
Journal of Medicinal Chemistry
|
September 28, 2024
Optimization of Potent, Efficacious, Selective and Blood-Brain Barrier Penetrating Inhibitors Targeting EGFR Exon20 Insertion Mutations
Clare Thomson, Erin Braybrooke, Nicola Colclough, et al.
Journal of Medicinal Chemistry
|
January 30, 2026
Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer
James S Scott, Laura Evans, Peter C Astles, et al.
Journal of Medicinal Chemistry
|
January 27, 2025
Highly Optimized CNS Penetrant Inhibitors of EGFR Exon20 Insertion Mutations
William McCoull, Clare Thomson, Erin Braybrooke, et al.
Page
of 1